Baird upgrades Humana stock rating on margin recovery outlook
Covered in this story
What has happened since
- Humana is down 1.0% since this was published, 11 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Humana
- Baird: $432 → $596 by Oct 2027 · Outperform via Investing.com
- Barclays: $398 → $515 by Sep 2027 · Overweight via 247wallst.com
- Wolfe Research: $387 → $450 by Aug 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $HUM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Humana →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.